Biotech Co. Illumina Inks $14M Deal To End Stock-Drop Suit
Biotechnology company Illumina Inc. reached a nearly $14 million deal with its investors to end securities fraud claims that it artificially inflated its stock prices by hiding declining sales from the...To view the full article, register now.
Already a subscriber? Click here to view full article